TearLab is an in-vitro diagnostic company commercializing a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. TEAR’s wholly owned subsidiary TearLab Research, Inc. develops technologies to enable eye care practitioners to test a range of biomarkers at the point-of-care. For more information, visit the company’s Web site: http://www.tearlab.com
Let us hear your thoughts below: